ABSTRACT
<p><b>OBJECTIVE</b>In China, people have relied on traditional Chinese medicine (TCM) for thousands of years to keep healthy and treat diseases. TCM also plays an important role in military health services and now forms a new discipline called military Chinese medicine (MCM). However, the type, quality and focus of research articles about MCM have not been reported. The present study was performed to analyze the growing trends of MCM and investigate China's contribution to military health services.</p><p><b>METHODS</b>China's MCM publications were retrieved from the PubMed database, as well as China National Knowledge Infrastructure, Wanfang Data and Chongqing VIP database from 2005 to 2014.</p><p><b>RESULTS</b>The study found that the number of published articles increased markedly from 2005 to 2014. Basic research studies comprised a small percentage of the literature. Among these studies, military training injury and special military environmental medicine were the most common research subjects in MCM. Military hospitals were the main institutions generating MCM literature.</p><p><b>CONCLUSION</b>The quality of MCM research is generally low, as indicated by the proportion of publications in core journals. Studies on MCM still lack high-quality publications and international cooperation.</p>
ABSTRACT
Military medicine has had a long history in China since the emergence of the war. Chinese medicine, especially Chinese herbs, was widely used in China as well as other Asian countries for the prevention and treatment of diseases in the military for hundreds of years. However, the use of Chinese medicine in military health service has never been well studied. In this article, we briefly summarize the application status of Chinese herbal medicine in military health service in China, putting particular emphasis on special military environment, in an attempt to build a bridge between Chinese medicine and military health service and promote the quality of health service for the military and maintain world peace.
Subject(s)
Humans , Drugs, Chinese Herbal , Therapeutic Uses , Environment , Health Services , Military Medicine , Military PersonnelABSTRACT
Primary liver cancer (PLC) is one kind of common malignant tumor. Due to its low rate of early diagnosis, most patients are preliminarily diagnosed of advanced cancer and have lost opportunities for radical surgery. Currently, the integrated treatment is applied to improve the prognosis of these patients and prolong the survival time. Recently, more attentions have been paid to systemic chemotherapy with the development of new generation of chemotherapeutic agents and the targeted therapy. A large number of clinical trials have revealed that systemic chemotherapy plays an important role in the treatment of PLC, including prolonging the survival time, controlling the development of cancer and improving the quality of life. This review summarizes the advance in systemic chemotherapy for PLC and the related issues. Copyright© 2014 by TUMOR.